<DOC>
	<DOC>NCT02722174</DOC>
	<brief_summary>The study aims to examine a battery of behavioral and questionnaire measures in 4 disorders clinically associated with impulsivity and in health controls, to: 1) investigate if the different populations have a distinct behavioral profile, and 2) to investigate if there are specific measures that are reliable and sensitive measures of impulsivity across diagnoses.</brief_summary>
	<brief_title>Fingerprinting of Impulsivity</brief_title>
	<detailed_description />
	<mesh_term>Impulsive Behavior</mesh_term>
	<mesh_term>Disruptive, Impulse Control, and Conduct Disorders</mesh_term>
	<criteria>Inclusion criteria: All cohorts: Males and females ages 1850. Healthy Control cohort: Volunteers in generally good Psychiatric and nonPsychiatric medical health Borderline Personality Disorder (2 cohorts): Subjects who meet Diagnostic and Statistical Manual of Mental DisordersV (DSMV) criteria for Borderline Personality Disorder Binge Eating Disorder cohort: Subjects who meet DSMV criteria for Binge Eating Disorder. Stimulant Use Disorder cohort: Subjects who meet DSMV criteria for current Stimulant Use Disorder, subtype cocaine, moderate or severe use Attention Deficit Hyperactivity Disorder cohort: Subjects who meet DSMV criteria for adult Attention Deficit Hyperactivity Disorder Exclusion criteria: General: Positive breathalyzer test for alcohol at any study visit History of clinically significant neurologic disorders or head trauma with loss of consciousness greater than 30 minutes Clinically significant nonpsychiatric medical disorder requiring ongoing treatment as judged by the investigator. Unwillingness or inability to sign a written informed consent form Pregnancy as assessed by a urine test for ßHuman Chorionic Gonadotropin (ßHCG) at screening visit Medical or physical contraindications for participation (see below), based on medical history interview, as judged by the investigator Unwilling to refrain from tobacco use one hour prior to testing until after conclusion of testing Healthy Controls: Current or past DSMV Axis II diagnoses of Cluster B Personality disorders Current or past DSMV Axis I diagnoses based on the Structured Clinical Interview for DSMV (SCID) (including the eating disorders and ADHD module) History of arrest or incarceration Positive urine drug screen for cannabis, cocaine, opiates, amphetamine, and benzodiazepines at any visit Current Tobacco Users Borderline Personality Disorder Subjects: Current or past DSMV Axis I diagnoses other than Tobacco Use disorder or Past Major Depressive Disorder Current or past DSMV Axis II diagnoses other than Cluster B personality disorders Positive urine drug screen for cannabis, cocaine, opiates, amphetamine, and benzodiazepines at any visit Antipsychotic medication or mood stabilizers taken within the last 30 days or change in antidepressant medication within the last 30 days. Binge Eating Disorder Subjects: Current or past DSMV Axis I diagnoses other than binge eating disorder (current bulimia also excluded) and Tobacco Use Disorder. Current or past DSMV Axis II diagnoses of Cluster B Personality disorders Positive urine drug screen for cannabis, cocaine, opiates, amphetamine, and benzodiazepines at any visit Stimulant Use Disorder, Cocaine Subtype Subjects: Current or past DSMV Axis I diagnoses other than Stimulant Use Disorder, minor Cannabis Use Disorder, minor alcohol use disorder and Tobacco Use Disorder , or Past Substance Induced Mood Disorder Current or past DSMV Axis II diagnoses of Cluster B Personality disorders Positive urine drug screen for opiates, amphetamine, and benzodiazepines at any visit ADHD Subjects: Current or past DSMV Axis I diagnoses other than ADHD Current or past DSMV Axis II diagnoses of Cluster B Personality disorders Stimulant medication taken the morning of behavioral testing. Positive urine drug screen for cannabis, cocaine, opiates, amphetamine, and benzodiazepines Unwilling or unable to withhold medications prescribed for treatment of ADHD on the morning of any clinic visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>